The number of exits in Switzerland is rising again. Swiss technology companies are no longer being acquired solely for their technology and team, but increasingly also for their market positioning...
Read More
Only a year after its incorporation, OBaris AG was acquired by Johnson & Johnson, marking the beginning of a new phase of innovation in drug delivery. As a pre-clinical medtec...
Read More
With marketing approvals in 10 European Union countries and Switzerland, Swiss Cardio Technologies commercializes its cardiovascular solution, Cardioplexol in multiple regions. Th...
Read More
The second tranche of the Series C round brings total funds raised to more than CHF 125 million. The proceeds will be used to progress with the Phase 3 trial of the lead product d...
Read More
Europe’s deep tech ecosystem has become a potent driver of innovation, standing strong despite broader venture capital market fluctuations. Switzerland is gaining recognition as a leading hub for ...
Read More